This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Obesity Science & Innovation
September 16-17, 2025
Thomas Michael Menino Convention & Exhibition CenterBoston, US

Wenge Zhong
CTO at Regor Pharmaceuticals
Speaker

Profile

Wenge Zhong, CTO & Cofounder of Regor Therapeutics Group. B.S., Beijing University; Ph. D. in Chemistry, California Institute of Technology; Postdoctoral Researcher, The Scripps Research Institute. Prior to Regor, Dr. Zhong worked at Amgen for 18 years, first at Amgen Thousand Oaks for 14 years and later as the Head of Discovery at the Amgen Asia R&D Center in Shanghai. At Regor, Dr. Zhong is responsible for building the cutting-edge innovation engine rCARDTM and leading all discovery programs.

Agenda Sessions

  • rCARDTM Accelerated Discovery of RGT-075 – A Leading Small Molecule Oral GLP1R Agonist for Obesity and Beyond

    10:55